News from sofie A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 10, 2021, 08:00 ET SOFIE gets greenlight from U.S. FDA to proceed to Phase II Pancreatic Cancer Study

SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has received clearance to proceed with its...

May 28, 2021, 07:00 ET SOFIE to Commercially Supply FDA-Approved PYLARIFY® (piflufolastat F 18) Injection

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and...

Mar 30, 2021, 07:00 ET SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has executed an assignment agreement...

Nov 12, 2020, 21:10 ET SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™ (18F-DCFPYL), a PSMA-targeted Prostate Cancer Imaging Agent

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has signed a commercial supply agreement ...

Jun 24, 2019, 10:00 ET SOFIE Breaks Ground On 30,000 Sq Ft Theranostic Center Of Excellence

SOFIE Inc. (SOFIE), a Theranostics company headquartered in Los Angeles, CA, expands its footprint in Totowa, NJ. The acquired space is being used...

Jun 21, 2019, 10:00 ET SOFIE And University Clinic Heidelberg Sign License Agreement For Theranostics That Target Cancer Associated Fibroblasts

SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class...

Jun 17, 2019, 10:00 ET Sofie Expands Its Network By Acquiring Cyclotope Radiopharmacy From Houston Cyclotron Partners

Los Angeles-based SOFIE Inc. (SOFIE), a molecular imaging and theranostic company, announces the acquisition of a Cyclotope Radiopharmacy from...

Oct 05, 2018, 08:00 ET SOFIE is Awarded $5M from Three Major SBIR Grants

Today SOFIE, an emerging theranostics company focused on Positron Emission Tomography (PET) tracers and radiopharmaceutical-based therapeutics, PET...

Sep 27, 2017, 13:00 ET Acquisition Of Zevacor Pharma Complete, Rebranding As SOFIE

Sofie Biosciences, Inc., the molecular imaging company specializing in novel tools for PET imaging and radiosynthesis of PET compounds, has today...